VIRIAL INFECTIONS: REPLICATION AND PATHOGENESIS MECHANISMS TO THERAPY Murine Models of Chronic Viral Infections and Associated Cancers

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• [Murine Models of Chronic Viral Infections and Associated Cancers].

  2022cited by this paper
• Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells

  2021cited by this paper
• Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions

  2021cited by this paper
• Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1

  2021cited by this paper
• Therapeutic DNA Vaccine Against HPV16-Associated Cancer.

  2021cited by this paper
• Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

  2021cited by this paper
• Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind

  2021cited by this paper
• Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining

  2021cited by this paper
• Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract

  2021influential reference
• Low dietary fiber promotes enteric expansion of a Crohn's disease-associated pathobiont independent of obesity.

  2021cited by this paper
• Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations

  2020cited by this paper
• Patient-derived xenografts as compatible models for precision oncology

  2020cited by this paper
• An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer

  2020cited by this paper
• Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses

  2020influential reference
• Establishment of a Patient‐Derived Xenograft Tumor From Hepatitis C–Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy

  2020cited by this paper
• Viral Infections: Negative Regulators of Apoptosis and Oncogenic Factors

  2020cited by this paper
• Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models

  2020cited by this paper
• SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function

  2020cited by this paper
• HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist

  2019cited by this paper
• It's the fiber, not the fat: significant effects of dietary challenge on the gut microbiome

  2019cited by this paper
• Pathological Pattern of Intrahepatic HBV in HCC is Phenocopied by PDX-Derived Mice: a Novel Model for Antiviral Treatment

  2019cited by this paper
• In Vivo Models of Oncoproteins Encoded by Kaposi’s Sarcoma-Associated Herpesvirus

  2019cited by this paper
• Sexual transmission of murine papillomavirus (MmuPV1) in Mus musculus

  2019cited by this paper
• An endothelial cell line infected by Kaposi’s sarcoma–associated herpes virus (KSHV) allows the investigation of Kaposi’s sarcoma and the validation of novel viral inhibitors in vitro and in vivo

  2019cited by this paper
• Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.

  2019cited by this paper
• A patient derived xenograft model of cervical cancer and cervical dysplasia

  2018cited by this paper
• Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV‐related head and neck cancer

  2018cited by this paper
• Animal Models to Study Hepatitis C Virus Infection

  2018cited by this paper
• HPV: Molecular pathways and targets.

  2018cited by this paper
• Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)

  2018cited by this paper
• Development of mouse models for analysis of human virus infections

  2017cited by this paper
• Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells

  2017cited by this paper
• Humanized chimeric mouse models of hepatitis B virus infection.

  2017influential reference
• Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

  2017cited by this paper
• Interrogating open issues in cancer precision medicine with patient-derived xenografts

  2017cited by this paper
• Humanized Mouse Models of Clinical Disease.

  2017cited by this paper
• Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis.

  2016influential reference
• Mouse models in oncoimmunology

  2016cited by this paper
• Transgenic Mouse Models of SV40-Induced Cancer.

  2016cited by this paper
• Athymic nude mice as an experimental model for cancer treatment.

  2016cited by this paper
• Animal models of human colorectal cancer: Current status, uses and limitations.

  2015cited by this paper
• LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

  2015cited by this paper
• Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors1

  2015cited by this paper
• One mouse, one patient paradigm: New avatars of personalized cancer therapy.

  2014cited by this paper
• HBV life cycle is restricted in mouse hepatocytes expressing human NTCP

  2014cited by this paper
• Humanized-BLT mouse model of Kaposi’s sarcoma-associated herpesvirus infection

  2014cited by this paper
• Characterization of EBV-related Lymphoproliferative Lesions Arising in Donor Lymphocytes of Transplanted Human Tumor Tissues in the NOG Mouse

  2014cited by this paper
• Mouse Models of Hepatitis B Virus Infection Comprising Host-Virus Immunologic Interactions

  2014cited by this paper
• New generation humanized mice for virus research: comparative aspects and future prospects.

  2013cited by this paper
• Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation

  2013cited by this paper
• HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses

  2013cited by this paper
• Immunotherapy in new pre-clinical models of HPV-associated oral cancers

  2013cited by this paper
• A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression

  2012cited by this paper
• IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the Skin

  2012cited by this paper
• Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus

  2012cited by this paper
• Animal models for HIV/AIDS research

  2012influential reference
• RAS oncogenes: weaving a tumorigenic web

  2011cited by this paper
• Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.

  2011cited by this paper
• Murine Gamma-herpesvirus Immortalization of Fetal Liver-Derived B Cells Requires both the Viral Cyclin D Homolog and Latency-Associated Nuclear Antigen

  2011cited by this paper
• A genetically humanized mouse model for hepatitis C virus infection

  2011cited by this paper
• Humanized mouse models to study human diseases

  2010cited by this paper
• Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review

  2010cited by this paper
• IL-17 enhances tumor development in carcinogen-induced skin cancer.

  2010cited by this paper
• Functional Mechanisms for Human Tumor Suppressors

  2010cited by this paper
• Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.

  2009cited by this paper
• The first 30 years of p53: growing ever more complex

  2009cited by this paper
• Murine models for HIV vaccination and challenge

  2008influential reference
• Mouse xenograft models vs GEM models for human cancer therapeutics

  2008cited by this paper
• The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

  2008cited by this paper
• Basic concept of development and practical application of animal models for human diseases.

  2008cited by this paper
• Establishment of human tumor xenografts in immunodeficient mice

  2007cited by this paper
• Maximizing mouse cancer models

  2007cited by this paper
• Murine models to evaluate novel and conventional therapeutic strategies for cancer.

  2007cited by this paper
• Development of humanized mice for the study of hepatitis C virus infection.

  2006cited by this paper
• Anti‐HCV therapies in chimeric scid‐Alb/uPA mice parallel outcomes in human clinical application

  2006cited by this paper
• An In vivo Platform for Translational Drug Development in Pancreatic Cancer

  2006cited by this paper
• Genetically engineered models have advantages over xenografts for preclinical studies.

  2006cited by this paper
• Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.

  2006cited by this paper
• SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation

  2005cited by this paper
• Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus

  2005cited by this paper
• HLA class I transgenic mice: development, utilisation and improvement

  2005cited by this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cited by this paper
• Viruses, chemicals and co-carcinogenesis

  2004cited by this paper
• Near completely humanized liver in mice shows human-type metabolic responses to drugs.

  2004cited by this paper
• Mouse models with modified p53 sequences to study cancer and ageing

  2003cited by this paper
• The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.

  2002cited by this paper
• Initial sequencing and comparative analysis of the mouse genome

  2002cited by this paper
• NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

  2002cited by this paper
• Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

  2002cited by this paper
• Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

  2001cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

  2001cited by this paper
• Model for Hepatitis C Virus-associated Hepatocarcinogenesis Oxidative Stress in the Absence of Inflammation in a Mouse Updated

  2001cited by this paper
• Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.

  2000cited by this paper
• Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse.

  2000cited by this paper
• The retinoblastoma gene family in differentiation and development

  1999cited by this paper
• Optimizing syngeneic orthotopic murine bladder cancer (MB49).

  1999cited by this paper
• Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites

  1999cited by this paper
• The role of p53 in tumour suppression: lessons from mouse models

  1999cited by this paper
• The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti‐HBV therapeutic agents

  1999cited by this paper

• Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses

  2023cites this paper